In immunocompromised patients, histoplasmosis may present as disseminated disease. We present a 52-year-old Caucasian male with symptoms of dyspepsia, postprandial epigastric pain, nausea, and nonbloody diarrhea. Upper and lower gastrointestinal endoscopies were suspicious for inflammatory bowel disease (IBD); however, biopsies were consistent with histoplasmosis, specifically in the duodenum.
Introduction
Histoplasma capsulatum is a dimorphic fungus that infects by inhalation of spores and can disseminate to the gastrointestinal system. Immunocompetent patients that acquire histoplasmosis generally have a self-limited respiratory infection [1, 2] . Patients who are immunosuppressed are unable to develop effective cell-mediated immunity against the organism and are likely to manifest symptomatic disease during the period of acute dissemination. Gastrointestinal histoplasmosis (GIH) is common in patients with primary lung involvement, but it is very unusual to present with isolated involvement of the gastrointestinal system.
Case Presentation
A 52-year-old Caucasian male with no pertinent past medical history presented with dyspepsia, nausea, bloating sensation, and postprandial abdominal pain, associated with nonbloody watery-brown diarrhea for six weeks. He also reported decreased appetite and unintentional weight loss of about 30 pounds (13.6 kg) in the last two months. He denied use of NSAIDS, coffee, alcohol, tobacco, or illicit drugs, any recent travel, or sick contacts. Vital signs were within normal limits. Physical exam was unremarkable except palpation eliciting mild diffuse pain in all four quadrants without rebound tenderness and negative Murphy sign. The patient was started on proton pump inhibitors (PPI). After two weeks, his followup complete blood count, basic metabolic panel, and liver function panel were unremarkable. The patient reported no relief of symptoms with PPI and was referred for endoscopy, which the patient initially refused. He returned to clinic after 2 months with worsening symptoms and further loss of 10 pounds and agreed to have an endoscopy.
EGD demonstrated the squamocolumnar junction at 40 cm with evidence of esophagitis ( Figure 1(a) ) and diffuse gastritis in the antrum extending to the body with a normal pylorus. A few scattered flat polypoidal lesions were found in the distal duodenum (Figure 1(b) ). Biopsies were taken from 
Discussion
Patients with GIH are usually asymptomatic and diagnosis is often made incidentally or in autopsy finding [1] . It most commonly presents with fever, bloody diarrhea, abdominal pain, and hepatosplenomegaly on exam [3, 4] . Some case reports revealed patients presenting with odynophagia or dysphagia as a result of extrinsic compression from mediastinal adenitis or from mediastinal fibrosis as seen in the primary pulmonary manifestation of histoplasmosis. On endoscopic evaluation, involvement has been seen to occur from the mouth to the rectum. The upper gastrointestinal tract can have oropharyngeal ulceration, perforation, and obstruction [3] . Gastric involvement can range from patchy or continuous superficial ulcerations to deep ulcers with or without perforation [5] . Small bowel involvement is commonly characterized as segmental inflammation and ulceration. The majority (90%) of lesions involve the lower GI tract, most commonly the ileocecal region or colon [4, 6] , likely due to this region's high presence of gut-associated lymphoid tissue (GALT), serving as potential entry sites for macrophages filled with H. capsulatum yeasts [4, 6] . In the largest case series of GIH in AIDS patients. Less than 4% of AIDS patients with GIH demonstrate duodenal disease, further confirming the unusual aspect of our patient's presentation [6] .
In stable patients, such as the patient in our case, itraconazole treatment for 6 to 18 months may be the initial choice [1, 2] . Prophylaxis with itraconazole is recommended in patients with HIV and CD4 cell counts <150 cells/mm 3 in specific areas where the incidence of histoplasmosis is >10 cases per patient-years. Antigen levels should be monitored during and for one year after therapy to ensure that there are no relapses. Our patient responded adequately to itraconazole treatment. It is imperative to wait for pathology results before initiating treatment for possible IBD with steroids, as it may exacerbate infectious processes in AIDS patients.
Conclusion
Disseminated histoplasmosis should be considered in immunocompromised patients, regardless of pulmonary symptoms, in endemic or nonendemic areas. Histoplasma capsulatum can mimic an innumerable amount of syndromes, from other infectious etiologies like tuberculosis to malignancy, PUD, and IBD, leading to inappropriate therapies and unnecessary surgical interventions.
